New targets for hematologic malignancies.
Dana-Farber Cancer Institute, Boston, Massachusetts.
James
J
Bradner
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D011173:Portraits as Topic
D000970:Antineoplastic Agents